Related references
Note: Only part of the references are listed.18F-FDG /18F-Choline Dual-Tracer PET Behavior and Tumor Differentiation in HepatoCellular Carcinoma. A Systematic Review
Jerome Ghidaglia et al.
FRONTIERS IN MEDICINE (2022)
PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?
Alessio Rizzo et al.
CANCERS (2022)
PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68Ga-PSMA-11 PET Using Cyclotron-Produced 8Ga
Scott M. Thompson et al.
HEPATOLOGY COMMUNICATIONS (2022)
Liver Imaging Reporting and Data System (LI-RADS) v2018: Review of the CT/MRI Diagnostic Categories
Devaraju Kanmaniraja et al.
CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES (2021)
[68Ga]Ga-Prostate-Specific Membrane Antigen PET/CT: a novel method for imaging patients with hepatocellular carcinoma
Jolanta Kunikowska et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
68Ga-PSMA PET/CT Versus 18F-FDG PET/CT for Imaging of Hepatocellular Carcinoma
Cihan Gundogan et al.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY (2021)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging
Hossein Jadvar et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
Nader Hirmas et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
11C-acetate positron emission tomography is more precise than 18F-fluorodeoxyglucose positron emission tomography in evaluating tumor burden and predicting disease risk of multiple myeloma
Miao Chen et al.
SCIENTIFIC REPORTS (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports
M. J. M. Uijen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
Oliver Sartor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Diagnostic Performance of PET Imaging Using Different Radiopharmaceuticals in Prostate Cancer According to Published Meta-Analyses
Salvatore Annunziata et al.
CANCERS (2020)
Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis
Li-Xing Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Radiolabelled PSMA PET/CT or PET/MRI in hepatocellular carcinoma (HCC): a systematic review
Francesco Dondi et al.
CLINICAL AND TRANSLATIONAL IMAGING (2020)
68Ga-Labeled Prostate-Specific Membrane Antigen Is a Novel PET/CT Tracer for Imaging of Hepatocellular Carcinoma: A Prospective Pilot Study
Mikhail Kesler et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy
Hans-Juergen Wester et al.
SEMINARS IN NUCLEAR MEDICINE (2019)
Detection rate of radiolabelled choline PET or PET/CT in hepatocellular carcinoma: an updated systematic review and meta-analysis
Giovanni Signore et al.
CLINICAL AND TRANSLATIONAL IMAGING (2019)
Intraindividual Comparison of 18F-PSMA-1007 and 18F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot Study
Frederik L. Giesel et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines
Carmen Ayuso et al.
EUROPEAN JOURNAL OF RADIOLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules
Eleonora Terzi et al.
JOURNAL OF HEPATOLOGY (2018)
C-11-acetate and F-18-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization
Sohyun Park et al.
MEDICINE (2018)
F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients
Frederik L. Giesel et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Preclinical Evaluation of 18F-PSMA-1007, a New Prostate-Specific Membrane Antigen Ligand for Prostate Cancer Imaging
Jens Cardinale et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Tumor angiogenesis revisited: Regulators and clinical implications
Roberto Ronca et al.
MEDICINAL RESEARCH REVIEWS (2017)
Systematic reviews and meta-analyses of diagnostic studies: a practical guideline
Ramin Sadeghi et al.
CLINICAL AND TRANSLATIONAL IMAGING (2017)
Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma
Robert F. Hanna et al.
ABDOMINAL RADIOLOGY (2016)
Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide
Rebecca E. Conway et al.
ANGIOGENESIS (2016)
Functional imaging in liver tumours
Maxime Ronot et al.
JOURNAL OF HEPATOLOGY (2016)
Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma A Systematic Review and Meta-analysis
Roger Chou et al.
ANNALS OF INTERNAL MEDICINE (2015)
Global Epidemiology of Hepatocellular Carcinoma An Emphasis on Demographic and Regional Variability
Katherine A. McGlynn et al.
CLINICS IN LIVER DISEASE (2015)
[18F]Fludeoxyglucose Positron Emission Tomography and Computed Tomography as a Prognostic Tool Before Liver Transplantation, Resection, and Loco-Ablative Therapies for Hepatocellular Carcinoma
Yael Asman et al.
LIVER TRANSPLANTATION (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
Hepatocellular Carcinoma: Diagnostic Performance of Multidetector CT and MR Imaging-A Systematic Review and Meta-Analysis
Yoon Jin Lee et al.
RADIOLOGY (2015)
Review of angiogenesis in hepatocellular carcinoma
Jun Muto et al.
HEPATOLOGY RESEARCH (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Diagnostic role of radiolabelled choline PET or PET/CT in hepatocellular carcinoma: a systematic review and meta-analysis
Francesco Bertagna et al.
HEPATOLOGY INTERNATIONAL (2014)
Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma
Matteo Angelo Manini et al.
JOURNAL OF HEPATOLOGY (2014)
Positron Emission Tomography-Computed Tomography in Liver Imaging
Bhuey Sharma et al.
SEMINARS IN ULTRASOUND CT AND MRI (2013)
2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer
Ying Chen et al.
CLINICAL CANCER RESEARCH (2011)
Quantification of choline compounds in human hepatic tumors by proton MR spectroscopy at 3 T
CW Li et al.
MAGNETIC RESONANCE IN MEDICINE (2005)
Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors
B Böhm et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Blood metabolism of [methyl-C-11]choline; implications for in vivo imaging with positron emission tomography
A Roivainen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
Share Paper
